Scholarlink

Background <p><i>Enterococcus faecium</i> (<i>E. faecium</i>) is an opportunistic pathogen frequently associated with urinary tract infections (UTIs). Its increasing multidrug resistance (MDR) is largely mediated by efflux pump systems that reduce intracellular antibiotic accumulation.</p> Objective <p>This study aimed to investigate antimicrobial resistance patterns of clinical <i>E. faecium</i> isolates and to evaluate the antibacterial and efflux pump-modulating effects of tungsten nanoparticles (WNPs) and functionalized multi-walled carbon nanotubes (MWCNTs).</p> Methods <p>Fifty-eight <i>E. faecium</i> isolates from UTI patients were subjected to antibiotic susceptibility testing and molecular detection of the efflux genes <i>efrA</i>, <i>efrB</i>, and <i>emeA</i>. WNPs and MWCNTs were synthesized, physicochemically characterized, and evaluated for antibacterial activity using minimum inhibitory concentration (MIC) assays. Quantitative real-time PCR was used to assess changes in efflux pump gene expression following nanoparticle exposure.</p> Results <p>High resistance rates were observed for erythromycin (86.2%), tetracycline (81.0%), fluoroquinolones, and vancomycin (48.3%), with approximately 85% of isolates classified as MDR. Efflux pump genes were detected in 72–86% of isolates. WNPs and MWCNTs exhibited MIC values of 750&#xa0;µg/mL and 375&#xa0;µg/mL, respectively. Treatment with sub-inhibitory concentrations of these nanoparticles resulted in significant downregulation (1.8- to 2-fold) of <i>efrA</i>, <i>efrB</i>, and <i>emeA</i> expression, indicating suppression of efflux-mediated resistance mechanisms.</p> Conclusions <p>Tungsten nanoparticles and functionalized MWCNTs demonstrate notable antibacterial activity against MDR <i>E. faecium</i> and effectively modulate efflux pump gene expression. These findings support their potential use as adjunctive agents to enhance antimicrobial efficacy against resistant <i>E. faecium</i> infections, warranting further optimization and in vivo validation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Modulation of efflux pump gene expression in Enterococcus faecium by tungsten nanoparticles and multi-walled carbon nanotubes

  • 期刊论文

  • 发表日期：

    2026年5月18日

查看全文
  • Mahsa Khosroparviz,
  • Akram Sadat Tabatabaee Bafroee,
  • Kumars Amini

摘要

Background

Enterococcus faecium (E. faecium) is an opportunistic pathogen frequently associated with urinary tract infections (UTIs). Its increasing multidrug resistance (MDR) is largely mediated by efflux pump systems that reduce intracellular antibiotic accumulation.

Objective

This study aimed to investigate antimicrobial resistance patterns of clinical E. faecium isolates and to evaluate the antibacterial and efflux pump-modulating effects of tungsten nanoparticles (WNPs) and functionalized multi-walled carbon nanotubes (MWCNTs).

Methods

Fifty-eight E. faecium isolates from UTI patients were subjected to antibiotic susceptibility testing and molecular detection of the efflux genes efrA, efrB, and emeA. WNPs and MWCNTs were synthesized, physicochemically characterized, and evaluated for antibacterial activity using minimum inhibitory concentration (MIC) assays. Quantitative real-time PCR was used to assess changes in efflux pump gene expression following nanoparticle exposure.

Results

High resistance rates were observed for erythromycin (86.2%), tetracycline (81.0%), fluoroquinolones, and vancomycin (48.3%), with approximately 85% of isolates classified as MDR. Efflux pump genes were detected in 72–86% of isolates. WNPs and MWCNTs exhibited MIC values of 750 µg/mL and 375 µg/mL, respectively. Treatment with sub-inhibitory concentrations of these nanoparticles resulted in significant downregulation (1.8- to 2-fold) of efrA, efrB, and emeA expression, indicating suppression of efflux-mediated resistance mechanisms.

Conclusions

Tungsten nanoparticles and functionalized MWCNTs demonstrate notable antibacterial activity against MDR E. faecium and effectively modulate efflux pump gene expression. These findings support their potential use as adjunctive agents to enhance antimicrobial efficacy against resistant E. faecium infections, warranting further optimization and in vivo validation.